SUBSCRIBE
SUBSCRIBE
News   FDA

Novartis AG Says FDA Approves Menveo Vaccination in Children, Not Infants

January 31, 2011 | 
1 min read
Bloomberg -- U.S. regulators approved Novartis AG’s Menveo meningococcal vaccine for use in children from 2 years of age, though they requested more information on use of the shot in infants.
FDA Approvals
Food and Drug Administration (FDA) Novartis
MORE ON THIS TOPIC
Facade of the FDA's office in Maryland
Regulatory
FDA Issued Myeloma, Alzheimer’s Approvals in July but Rejected Two CGTs
July 31, 2025
 · 
10 min read
 · 
Tristan Manalac
FDA CDER director George Tidmarsh speaking in an FDA video
Government
New CDER Head Tidmarsh Will Sub In At Biologics Group After Prasad’s Exit
July 30, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Insight in business on black stock illustration
FDA
Exit Stage Right: With Prasad Out, Analysts Hope for More Traditional Replacement
July 30, 2025
 · 
5 min read
 · 
Annalee Armstrong
Podcast
Sarepta Gets Reprieve, RFK Jr.’s New Changes, Roche’s Alzheimer’s Comeback and Q2 Earnings
July 30, 2025
 · 
2 min read
 · 
Heather McKenzie